Related references
Note: Only part of the references are listed.Drug interactions and adverse events associated with antimycotic drugs used for invasive aspergillosis in hematopoietic SCT
S. S. Egger et al.
BONE MARROW TRANSPLANTATION (2010)
Incidence of risk factors for developing hyperkalemia when using ACE inhibitors in cardiovascular diseases
Omalhassan Amir et al.
PHARMACY WORLD & SCIENCE (2009)
Tubular site of renal sodium retention in ascitic liver cirrhosis evaluated by lithium clearance
P. ANGELI et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2008)
Adverse drug reaction-related hospitalisations: a population-based cohort study
Cornelis S. van der Hooft et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data
DA Leon et al.
LANCET (2006)
Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients
A Corsonello et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Dose adjustment in patients with liver disease
F Delco et al.
DRUG SAFETY (2005)
Assessment of intestinal permeability and absorption in cirrhotic patients with ascites using combined sugar probes
MJ Zuckerman et al.
DIGESTIVE DISEASES AND SCIENCES (2004)
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients
M Pirmohamed et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Drug use for non-hepatic associated conditions in patients with liver cirrhosis
MI Lucena et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Multicenter hospital study on prescribing patterns for prophylaxis and treatment of complications of cirrhosis
MI Lucena et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Epidemiology of drug exposure and adverse drug reactions in two Swiss departments of internal medicine
K Fattinger et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Share Paper
